Additional Metadata
Keywords circulating biomarkers, EGFR, immunotherapy, NSCLC, predictive biomarkers
Persistent URL dx.doi.org/10.2217/pgs-2019-0150, hdl.handle.net/1765/122727
Journal Pharmacogenomics
Citation
Re, M.D. (Marzia Del), Addeo, A. (Alfredo), Passaro, A. (Antonio), Petrini, I. (Iacopo), van Schaik, R.H.N, & Danesi, R. (2019). Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment. Pharmacogenomics, 20(18), 1255–1257. doi:10.2217/pgs-2019-0150